| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.044 | 0 | 0 | 0 | - | - | - | - | - | - |
| Total Income - EUR | 5.044 | 0 | 0 | 0 | - | - | - | - | - | - |
| Total Expenses - EUR | 38.142 | 7.512 | 5.284 | 119 | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | -33.098 | -7.512 | -5.284 | -119 | - | - | - | - | - | - |
| Net Profit/Loss - EUR | -33.249 | -7.512 | -5.284 | -119 | - | - | - | - | - | - |
| Employees | 3 | 1 | 1 | 0 | - | - | - | - | - | - |
Check the financial reports for the company - Wizzpharma International Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 356 | 130 | 0 | 0 | - | - | - | - | - | - |
| Current Assets | 14.842 | 15.699 | 16.285 | 15.986 | - | - | - | - | - | - |
| Inventories | 119 | 39 | 38 | 38 | - | - | - | - | - | - |
| Receivables | 14.702 | 15.073 | 15.198 | 14.918 | - | - | - | - | - | - |
| Cash | 22 | 587 | 1.049 | 1.030 | - | - | - | - | - | - |
| Shareholders Funds | -93.904 | -100.458 | -104.042 | -102.252 | - | - | - | - | - | - |
| Social Capital | 90 | 89 | 88 | 86 | - | - | - | - | - | - |
| Debts | 109.102 | 116.286 | 120.327 | 118.237 | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5510 - 5510" | |||||||||
| CAEN Financial Year |
5510
|
|||||||||
Comments - Wizzpharma International Srl